醋酸环丙孕酮-14C与炔雌醇-3H口服包衣片（SH B 209 AB）后的生物利用度和药代动力学 - Suppr

Suppr

超能文献

Bio-availability and pharmacokinetics of cyproterone acetate-14C and ethinyloestradiol-3H after oral administration as a coated tablet (SH B 209 AB).

作者信息

Speck U, Wendt H, Schulze P E, Jentsch D

出版信息

Contraception. 1976 Aug;14(2):151-63. doi: 10.1016/0010-7824(76)90083-4.

DOI:10.1016/0010-7824(76)90083-4

PMID:949892

Abstract

摘要

相似文献

Bio-availability and pharmacokinetics of cyproterone acetate-14C and ethinyloestradiol-3H after oral administration as a coated tablet (SH B 209 AB).醋酸环丙孕酮-14C与炔雌醇-3H口服包衣片（SH B 209 AB）后的生物利用度和药代动力学

Contraception. 1976 Aug;14(2):151-63. doi: 10.1016/0010-7824(76)90083-4.

Plasma levels of active ingredients after single and repeated administration of a new oral contraceptive containing 2 mg of cyproterone acetate and 50 micrograms of ethinyl estradiol (DIANE) to five young women.对五名年轻女性单次及重复服用一种含2毫克醋酸环丙孕酮和50微克炔雌醇的新型口服避孕药（DIANE）后活性成分的血浆水平。

Acta Obstet Gynecol Scand Suppl. 1979;88:27-31. doi: 10.3109/00016347909157226.

Pharmacokinetics of cyproterone acetate and ethinylestradiol in 15 women who received a combination oral contraceptive during three treatment cycles.醋酸环丙孕酮和炔雌醇在15名在三个治疗周期中接受复方口服避孕药的女性体内的药代动力学。

Contraception. 1993 Dec;48(6):557-75. doi: 10.1016/0010-7824(93)90118-q.

Bioavailability and pharmacokinetics of cyproterone acetate after oral administration of 2.0 mg cyproterone acetate in combination with 50 micrograms ethinyloestradiol to 6 young women.对6名年轻女性口服2.0毫克醋酸环丙孕酮与50微克炔雌醇联合制剂后，醋酸环丙孕酮的生物利用度和药代动力学。

Contraception. 1977 May;15(5):579-88. doi: 10.1016/0010-7824(77)90108-1.

Interaction of rifampicin treatment with pharmacokinetics and metabolism of ethinyloestradiol in man.利福平治疗与人炔雌醇药代动力学和代谢的相互作用。

Acta Endocrinol (Copenh). 1977 May;85(1):189-197. doi: 10.1530/acta.0.0850189.

[Bioavailability and pharmacokinetics of 14C-cyproterone acetate after administration as a 50-mg tablet (author's transl)].50毫克片剂形式给药后醋酸环丙孕酮14C的生物利用度和药代动力学（作者译）

Arzneimittelforschung. 1976;26(9):1717-20.

Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives.多毛症的长期治疗：去氧孕烯与醋酸环丙孕酮在口服避孕药中的比较。

Fertil Steril. 1991 May;55(5):877-81. doi: 10.1016/s0015-0282(16)54291-5.

Effects of ethinyl estradiol combined with desogestrel and cyproterone acetate on glucose tolerance and insulin response to an oral glucose load: a one-year randomized, prospective, comparative trial.

Am J Obstet Gynecol. 1990 Jul;163(1 Pt 2):378-81. doi: 10.1016/0002-9378(90)90586-v.

Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.长期服用含炔雌醇和醋酸环丙孕酮的口服避孕药对多囊卵巢综合征女性脂质代谢的影响。

Acta Obstet Gynecol Scand. 1995 Jan;74(1):56-60. doi: 10.3109/00016349509009945.

The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women.醋酸环丙孕酮 - 炔雌醇联合疗法对多毛症女性血清脱氢表雄酮、雄烯二酮和睾酮水平的影响。

Acta Endocrinol (Copenh). 1977 Feb;84(2):333-42. doi: 10.1530/acta.0.0840333.

引用本文的文献

Progestogens with antiandrogenic properties.具有抗雄激素特性的孕激素。

Drugs. 2003;63(5):463-92. doi: 10.2165/00003495-200363050-00003.

The pharmacokinetics of lisuride hydrogen maleate in rat, rabbit and rhesus monkey.

Eur J Drug Metab Pharmacokinet. 1981;6(3):207-19. doi: 10.1007/BF03189490.

The pharmacokinetics and biotransformation of 14C-lisuride hydrogen maleate in rhesus monkey and in man.14C-马来酸麦角乙脲在恒河猴和人体内的药代动力学及生物转化

Eur J Drug Metab Pharmacokinet. 1984 Oct-Dec;9(4):347-57. doi: 10.1007/BF03189685.

Clinical pharmacokinetics of oral contraceptive steroids.口服避孕甾体激素的临床药代动力学。

Clin Pharmacokinet. 1983 Mar-Apr;8(2):95-136. doi: 10.2165/00003088-198308020-00001.

Pharmacokinetics of bromerguride, a new dopamine-antagonistic ergot derivative in rat and dog.溴麦角环肽（一种新型多巴胺拮抗麦角衍生物）在大鼠和犬体内的药代动力学

Eur J Drug Metab Pharmacokinet. 1987 Jan-Mar;12(1):31-40. doi: 10.1007/BF03189859.

The pharmacokinetics and biotransformation of the new benzodiazepine lormetazepam in humans. I. Absorption, distribution, elimination and metabolism of lormetazepam-5-14C.新型苯二氮䓬类药物氯美扎酮在人体中的药代动力学和生物转化。I. 氯美扎酮-5-14C的吸收、分布、消除和代谢

Eur J Drug Metab Pharmacokinet. 1979;4(4):237-43. doi: 10.1007/BF03189433.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验